Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer (Q36508067)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 September 2012

Language	Label	Description	Also known as
English	Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer	scientific article published on 28 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

phase I clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Francisco J Esteva

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ana Maria Gonzalez-Angulo

3

object named as

Ana M Gonzalez-Angulo

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Gabriel N Hortobagyi

9

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Stacy L Moulder

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

James L Murray

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Marjorie C Green

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Kimberly B Koenig

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Sai-Ching Yeung

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

28 September 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

71

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

63-72

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

In Vitro Cytochrome P450-Mediated Metabolism of Exemestane

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Multidisciplinary strategy for managing cardiovascular risks when treating patients with early breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Measures of response: RECIST, WHO, and new alternatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Estrogen carcinogenesis in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Insulin-like growth factor and breast cancer risk: evidence from observational studies

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Obesity, adipocytokines, and insulin resistance in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Monoclonal antibodies, small molecules, and vaccines in the treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Prognostic molecular markers in early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young males

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Mitochondrial metabolism and type-2 diabetes: a specific target of metformin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Growth factor receptors in breast cancer: potential for therapeutic intervention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Molecular prognostic factors for breast cancer metastasis and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Epidemiology of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Locally advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

30 September 2017

Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

28 June 2018

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

28 June 2018

Disposition of metformin (N,N-dimethylbiguanide) in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

28 June 2018

A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Treatment of advanced hormone-sensitive breast cancer in postmenopausal women with exemestane alone or in combination with celecoxib

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Serum levels of leptin, insulin, and lipids in relation to breast cancer in china

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Anthropometric measures, plasma adiponectin, and breast cancer risk.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-1977-9

21 January 2018

Endocrine and clinical effects of exemestane (PNU 155971), a novel steroidal aromatase inhibitor, in postmenopausal breast cancer patients: a phase I study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

21 September 2018

Early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3536885

21 October 2018

Residual risk of breast cancer recurrence 5 years after adjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23053261

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00280-012-1977-9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

release_z3mfxqyn5bbijgmh7sliabhlga

1 reference

https://api.fatcat.wiki/v0/release/z3mfxqyn5bbijgmh7sliabhlga

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23053261%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36508067&oldid=2198982391"